Dynavax Technologies Corporation logo

Dynavax Technologies Corporation

NASDAQ:DVAX

Overview | Financials
Company Name Dynavax Technologies Corporation
Symbol DVAX
Currency USD
Price 12.1
Market Cap 1,583,793,200
Dividend Yield 0%
52-week-range 10.48 - 15.15
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Ryan Spencer
Website https://www.dynavax.com

An error occurred while fetching data.

About Dynavax Technologies Corporation

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.

Related Stocks

Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc.

SUPN

27.08 USD

Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

XENE

38.36 USD

Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

TVTX

7.34 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

181.96 USD

ImmunityBio, Inc. logo

ImmunityBio, Inc.

IBRX

5.6 USD

Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc.

ESTA

47.43 USD

Addus HomeCare Corporation logo

Addus HomeCare Corporation

ADUS

118.45 USD

Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated

LGND

80.15 USD

Vaxcyte, Inc. logo

Vaxcyte, Inc.

PCVX

73.93 USD

ModivCare Inc. logo

ModivCare Inc.

MODV

27.18 USD

Financials

Numbers are in millions USD

Numbers are in millions USD